4.7 Letter

Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14++CD16 +/CD14+CD16++) monocytes in rheumatoid arthritis patient

Journal

BLOOD
Volume 119, Issue 22, Pages 5329-5330

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2012-02-412551

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available